Invivyd to Participate in Upcoming Investor Conferences
October 31 2023 - 4:01PM
Invivyd, Inc. (Nasdaq: IVVD), a clinical-stage biopharmaceutical
company on a mission to protect the vulnerable from serious viral
infectious diseases, today announced that it will present at the
following investor conferences:
Guggenheim 5th Annual
Inflammation, Neurology & Immunology (INI)
ConferenceFireside Chat Date: Tuesday, November 7,
2023Fireside Chat Time: 3:50 PM ETLocation: New York, NY
Evercore ISI 6th
Annual HealthCONx ConferenceFireside Chat Date:
Thursday, November 30, 2023Fireside Chat Time: 10:50 AM ETLocation:
Miami, FL
Live webcasts of the fireside chats will be available in the
investor section of the company's website at investors.invivyd.com
and will be archived for approximately 30 days following the
events.
About InvivydInvivyd, Inc. (Nasdaq: IVVD) is a
biopharmaceutical company on a mission to rapidly and perpetually
deliver antibody-based therapies that protect vulnerable people
from the devastating consequences of circulating viral threats,
beginning with SARS-CoV-2. Invivyd’s technology works at the
intersection of evolutionary virology, predictive modeling, and
antibody engineering, and is designed to identify high-quality,
long-lasting antibodies with the potential to resist viral escape.
The company is generating a robust pipeline of product candidates
which could be used in prevention or treatment of serious viral
diseases, starting with COVID-19 and expanding into influenza and
other high-need indications.
Visit https://invivyd.com/ to learn
more.Contacts:
Scott Young(781) 208-1747syoung@invivyd.com
Gabriella Linville-Engler(781) 208-0160gengler@invivyd.com
Invivyd (NASDAQ:IVVD)
Historical Stock Chart
From May 2024 to May 2024
Invivyd (NASDAQ:IVVD)
Historical Stock Chart
From May 2023 to May 2024